Cannabis
MedReleaf Corp. (TSE:$LEAF), which is a licensed producer of marijuana-based pharmaceutical products, will begin trading following its Initial Public Offering (IPO) on Wednesday, June 7, 2017. After trading commences, MedReleaf is predicted to become Canada’s ... [Read]